Gene · 28402
Papers3,091
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
561 to 580 of 3,091
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Implementation of International Prognostic Index with flow cytometry immunophenotyping for better risk stratification of chronic lymphocytic leukemia. | Eur J Haematol | 2022 | 35871396 | PubTator, text mining | PubMed |
| Myasthenia gravis-specific aberrant neuromuscular gene expression by medullary thymic epithelial cells in thymoma. | Nat Commun | 2022 | 35869073 | PubTator, text mining | PubMed |
| Immunoglobulin A antibody composition is sculpted to bind the self gut microbiome. | Sci Immunol | 2022 | 35857580 | PubTator, text mining | PubMed |
| Adding Umbralisib and Ublituximab (U2) to Ibrutinib in Patients with CLL: A Phase II Study of an MRD-Driven Approach. | Clin Cancer Res | 2022 | 35852793 | PubTator, text mining | PubMed |
| Second primary malignancies in chronic lymphocytic leukaemia: Skin, solid organ, haematological and Richter's syndrome. | EJHaem | 2022 | 35846218 | PubTator, text mining | PubMed |
| Characterization of real-world treatment practices and outcomes among patients with chronic lymphocytic leukemia treated in a Finnish tertiary center. | EJHaem | 2022 | 35846189 | PubTator, text mining | PubMed |
| Mantle cell lymphoma treatment options for elderly/unfit patients: A systematic review. | EJHaem | 2022 | 35846186 | PubTator, text mining | PubMed |
| A Ferroptosis Molecular Subtype-Related Signature for Predicting Prognosis and Response to Chemotherapy in Patients with Chronic Lymphocytic Leukemia. | Biomed Res Int | 2022 | 35845961 | PubTator, text mining | PubMed |
| Spectrum of Immune Checkpoint Inhibitor Anemias: Results From a Single Center, Early-Phase Clinical Trials Case Series Experience. | J Hematol | 2022 | 35837373 | PubTator, text mining | PubMed |
| TP53 Mutations Identified Using NGS Comprise the Overwhelming Majority of TP53 Disruptions in CLL: Results From a Multicentre Study. | Front Oncol | 2022 | 35837095 | PubTator, text mining | PubMed |
| Combined BCL2 and BTK inhibition in CLL demonstrates efficacy after monotherapy with both classes. | Blood Adv | 2022 | 35834733 | PubTator, text mining | PubMed |
| Machine-designed biotherapeutics: opportunities, feasibility and advantages of deep learning in computational antibody discovery. | Brief Bioinform | 2022 | 35830864 | PubTator, text mining | PubMed |
| γδ T, NKT, and MAIT Cells During Evolution: Redundancy or Specialized Functions? | J Immunol | 2022 | 35821101 | PubTator, text mining | PubMed |
| MiR-146b-5p regulates IL-23 receptor complex expression in chronic lymphocytic leukemia cells. | Blood Adv | 2022 | 35819446 | PubTator, text mining | PubMed |
| Regulation of S100As Expression by Inflammatory Cytokines in Chronic Lymphocytic Leukemia. | Int J Mol Sci | 2022 | 35805957 | PubTator, text mining | PubMed |
| CD73 Promotes Chronic Lymphocytic Leukemia. | Cancers (Basel) | 2022 | 35804900 | PubTator, text mining | PubMed |
| Immunoglobulin Gene Sequence as an Inherited and Acquired Risk Factor for Chronic Lymphocytic Leukemia. | Cancers (Basel) | 2022 | 35804817 | PubTator, text mining | PubMed |
| Dissecting the treatment-naive ecosystem of human melanoma brain metastasis. | Cell | 2022 | 35803246 | PubTator, text mining | PubMed |
| Serum amyloid P component and pro-platelet basic protein in extracellular vesicles or serum are novel markers of liver fibrosis in chronic hepatitis C patients. | PLoS One | 2022 | 35797333 | PubTator, text mining | PubMed |
| Plasma and memory antibody responses to Gamma SARS-CoV-2 provide limited cross-protection to other variants. | J Exp Med | 2022 | 35796685 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/28402/papers?page=29